These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Mutation analysis of an Ashkenazi Jewish family with Gaucher disease in three successive generations. Kolodny EH; Firon N; Eyal N; Horowitz M Am J Med Genet; 1990 Aug; 36(4):467-72. PubMed ID: 2117855 [TBL] [Abstract][Full Text] [Related]
25. Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Kramer PL; de Leon D; Ozelius L; Risch N; Bressman SB; Brin MF; Schuback DE; Burke RE; Kwiatkowski DJ; Shale H Ann Neurol; 1990 Feb; 27(2):114-20. PubMed ID: 2317008 [TBL] [Abstract][Full Text] [Related]
27. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect. Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102 [TBL] [Abstract][Full Text] [Related]
28. MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population. Behar DM; Hammer MF; Garrigan D; Villems R; Bonne-Tamir B; Richards M; Gurwitz D; Rosengarten D; Kaplan M; Della Pergola S; Quintana-Murci L; Skorecki K Eur J Hum Genet; 2004 May; 12(5):355-64. PubMed ID: 14722586 [TBL] [Abstract][Full Text] [Related]
29. Cystic fibrosis in Jews: frequency and mutation distribution. Kerem B; Chiba-Falek O; Kerem E Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623 [TBL] [Abstract][Full Text] [Related]
36. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. Tobias DH; Eng C; McCurdy LD; Kalir T; Mandelli J; Dottino PR; Cohen CJ Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794 [TBL] [Abstract][Full Text] [Related]
37. Evidence of a generalized metabolic defect in patients with hereditary chondrocalcinosis. Increased inorganic pyrophosphate in cultured fibroblasts and lymphoblasts. Lust G; Faure G; Netter P; Gaucher A; Seegmiller JE Arthritis Rheum; 1981 Dec; 24(12):1517-21. PubMed ID: 6275862 [TBL] [Abstract][Full Text] [Related]
38. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903 [TBL] [Abstract][Full Text] [Related]
39. The RNASEL 471delAAAG allele and prostate cancer in Ashkenazi Jewish men. Kotar K; Hamel N; Thiffault I; Foulkes WD J Med Genet; 2003 Mar; 40(3):e22. PubMed ID: 12624151 [No Abstract] [Full Text] [Related]
40. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer. Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]